SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Zydus Lifesciences

BSE: 532321 29 Jun 2025
Healthcare
₹ 952.95
Zydus Lifesciences Limited specializes in Pharmaceuticals within the Healthcare sector.

Zydus Lifesciences - Share Price & Details

Market Cap
₹98,792
High /Low
1,324 / 795.0
Stock P/E
21.2
Book Value
₹238.0
Dividend Yield
1.12
ROCE
24.4
ROE
₹21.3
Face Value
1.0
PEG Ratio
0.81
EVEBITDA
₹13.5
Debt
3,213
CMP / FCF
32.4
Debt to equity
₹0.13
NP Ann
4,673
High price all time
1,324
Piotroski score
₹6.0
Graham Number
491.0
No. Eq. Shares
101.0
Net CF
₹419
Net profit
4,673
Price to book value
4.12
Interest Coverage
₹38.6
Low price all time
25.5
Industry PE
32.7
Reserves
₹23,852
Free Cash Flow
₹5,116

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
Zydus Lifesciences Limited60050.028137.058196.027.9698,79221.2
Mankind Pharma Limited23459.13824.621265.99.259630648.5
LUPIN LTD.45344.612913.544856.728.218838026.9

Peer Comparison Chart


About Zydus Lifesciences

Zydus Lifesciences Limited, with Security Code 532321, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Zydus Healthcare appoints Swati Dalal as Managing Director and Additional Director

(22 Jun 2025)
Zydus Healthcare Ltd, a wholly-owned subsidiary of Zydus Lifesciences Ltd, has appointed Swati Dalal as its new Managing Director and...
Read more →

Zydus Lifesciences Sees Significant Open Interest Surge Amid Active Market Participation

(15 Jun 2025)
Zydus Lifesciences Ltd has seen a significant rise in open interest, reaching 17,947 contracts, alongside a trading volume of 20,461 contracts.
Read more →

Swati Dalal joins Zydus Healthcare as MD

(15 Jun 2025)
Ahmedabad: Zydus Healthcare Limited, a wholly owned subsidiary of Zydus Lifesciences Limited, has appointed Swati Dalal as its new Managing...
Read more →

Zydus Lifesciences Shares Gain 1% on EIR from USFDA

(15 Jun 2025)
Shares of Zydus Lifesciences Ltd were trading in the green and 1% higher on 12 June after the company secured the EIR from the USFDA.
Read more →

ZYDUS LIFE RECEIVES USFDA EIR FOR GUJARAT FACILITY

(12 Jun 2025)
(12 Jun 2025, 09:55). Zydus Life receives USFDA EIR for Gujarat facility. Zydus Lifesciences has informed that it has received the establishment inspection...
Read more →

Zydus Lifesciences shares in focus after USFDA issues EIR to Ankleshwar facility

(12 Jun 2025)
Zydus Lifesciences Share Price | The said facility underwent an inspection Between 10-14 March, 2025, and the inspection has been classified...
Read more →